bpc 157 asthma BPC-157 Peptide: Enhance Healing and Recovery | Desert Mobile Medical Neuropeptides in asthma, chronic obstructive

Comment: A commenter recommended evaluating receiving facilities instead of REHs for numerator component (3) which evaluates the time from Decision to Transfer (order) to the ED departure

doi:10.1086/321262 Reynolds EH

Every synthesised batch undergoes rigorous third-party chromatography to guarantee biological efficacy

All references FDA: Concerns with unapproved GLP-1 drugs used for weight loss NEJM (2023): Retatrutide Phase 2 trial in obesity Eli Lilly: Phase 2 retatrutide results published in NEJM Eli Lilly (Dec 2025): Phase 3 TRIUMPH-4 topline results announcement ClinicalTrials.gov: NCT05882045 (TRIUMPH-3) Drugs.com: Retatrutide status & timeline Lilly Trials: TRIUMPH-3 summary page